A guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: a systematic review sponsored by the world workshop on oral …

A Wolff, RK Joshi, J Ekström, D Aframian… - Drugs in R&d, 2017 - Springer
Background Medication-induced salivary gland dysfunction (MISGD), xerostomia (sensation
of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of …

Measures of anxiety: state‐trait anxiety inventory (STAI), Beck anxiety inventory (BAI), and Hospital anxiety and Depression scale‐anxiety (HADS‐A)

LJ Julian - Arthritis care & research, 2011 - Wiley Online Library
Purpose. To measure via self-report the presence and severity of current symptoms of
anxiety and a generalized propensity to be anxious. Versions of this measure are available …

Fibromyalgia pathogenesis and treatment options update

S Chinn, W Caldwell, K Gritsenko - Current pain and headache reports, 2016 - Springer
This review article presents and summarizes up-to-date literature on the clinical
manifestations, diagnosis, pathophysiological mechanisms, and treatment options for …

Treatment of chronic non-cancer pain

DC Turk, HD Wilson, A Cahana - The Lancet, 2011 - thelancet.com
Chronic pain is a pervasive problem that affects the patient, their significant others, and
society in many ways. The past decade has seen advances in our understanding of the …

Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia

MPT Lunn, RAC Hughes… - Cochrane database of …, 2014 - cochranelibrary.com
Background Duloxetine is a balanced serotonin and noradrenaline reuptake inhibitor
licensed for the treatment of major depressive disorders, urinary stress incontinence and the …

Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia

P Welsch, N Üçeyler, P Klose, B Walitt… - Cochrane Database …, 2018 - cochranelibrary.com
Background Fibromyalgia is a clinically defined chronic condition of unknown etiology
characterized by chronic widespread pain that often co‐exists with sleep disturbances …

Comparison of amitriptyline and us food and drug administration–approved treatments for fibromyalgia: a systematic review and network meta-analysis

HM Farag, I Yunusa, H Goswami, I Sultan… - JAMA Network …, 2022 - jamanetwork.com
Importance Amitriptyline is an established medication used off-label for the treatment of
fibromyalgia, but pregabalin, duloxetine, and milnacipran are the only pharmacological …

Update on treatment guideline in fibromyalgia syndrome with focus on pharmacology

S Kia, E Choy - Biomedicines, 2017 - mdpi.com
Fibromyalgia syndrome (FMS) is a chronic condition with unknown aetiology. The
pathophysiology of the disease is incompletely understood; despite advances in our …

An update on pharmacotherapy for the treatment of fibromyalgia

EP Calandre, F Rico-Villademoros… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: Fibromyalgia is a syndrome characterized by chronic generalized pain in
addition to different symptoms such as fatigue, sleep disturbances, stiffness, cognitive …

The common link between functional somatic syndromes may be central sensitisation

JH Bourke, RM Langford, PD White - Journal of psychosomatic research, 2015 - Elsevier
Objectives Functional somatic syndromes are common and disabling conditions that all
include chronic pain, and which may be related to central nervous system sensitisation …